ASLAN Pharmaceuticals Ltd ADR (NASDAQ:ASLN)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ASLN
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ASLN
- Market Cap$77.880m
- SymbolNASDAQ:ASLN
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS04522R1014
Company Profile
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology and oncology-focused biopharmaceutical company. It is engaged in developing treatments to transform the lives of patients. The company has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Latest ASLN news
Currently there for this company. Visit our news hub for other news .